Literature DB >> 15759182

Radiofrequency ablation in the liver close to the bile ducts: can intraductal cooling offer protection?

U Jersenius1, D Arvidsson, J Lindholm, S Anttila, A Elvin.   

Abstract

BACKGROUND: One complication of radiofrequency ablation (RFA) of the liver is biliary duct damage. Intraductal cooling (IDC) has been proposed as a means of protection.
METHODS: In the first experiment, designed to evaluate the influence of IDC on the RFA procedure per se and on lesion formation, lesions were created in vivo in pig liver with and without IDC. The RFA needle was placed with a 1.5-cm safety margin from the bile ducts. In the second experiment, designed to evaluate the potential protective effects of IDC, lesions were created close to a bile duct with and without IDC.
RESULTS: With the safety margin, the RFA parameters and lesion size were not negatively affected by IDC. Microscopic examination revealed that IDC had a protective effect in most of the lesions created close to a bile duct.
CONCLUSIONS: The IDC procedure was feasible and had no negative effect on the RFA procedure or the lesions. However, the protective effect of IDC was not statistically significant (p = 0.12).

Entities:  

Mesh:

Year:  2005        PMID: 15759182     DOI: 10.1007/s00464-004-9074-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  22 in total

1.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.

Authors:  David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

Review 2.  Hepatocellular carcinoma.

Authors:  E A Akriviadis; J M Llovet; S C Efremidis; D Shouval; R Canelo; B Ringe; W C Meyers
Journal:  Br J Surg       Date:  1998-10       Impact factor: 6.939

3.  New methods for arterial diameter measurement from B-mode images.

Authors:  R W Stadler; W C Karl; R S Lees
Journal:  Ultrasound Med Biol       Date:  1996       Impact factor: 2.998

4.  Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size.

Authors:  E J Patterson; C H Scudamore; D A Owen; A G Nagy; A K Buczkowski
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

5.  Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications.

Authors:  H Choi; E M Loyer; R A DuBrow; H Kaur; C L David; S Huang; S Curley; C Charnsangavej
Journal:  Radiographics       Date:  2001-10       Impact factor: 5.333

6.  Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations.

Authors:  A Siperstein; A Garland; K Engle; S Rogers; E Berber; A String; A Foroutani; T Ryan
Journal:  Surg Endosc       Date:  2000-04       Impact factor: 4.584

Review 7.  Complications of radiofrequency coagulation of liver tumours.

Authors:  S Mulier; P Mulier; Y Ni; Y Miao; B Dupas; G Marchal; I De Wever; L Michel
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

8.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

Review 9.  Radiofrequency ablation of hepatic metastases.

Authors:  Alexander A Parikh; Steven A Curley; Bruno D Fornage; Lee M Ellis
Journal:  Semin Oncol       Date:  2002-04       Impact factor: 4.929

10.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

View more
  1 in total

1.  Improvised biliary cooling technique for radiofrequency ablation of liver tumours close to central bile ducts.

Authors:  M Elshaer; J White; S S Liau
Journal:  Ann R Coll Surg Engl       Date:  2020-08-24       Impact factor: 1.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.